Rx-360: An Industry Group Like No Other

Rx-360 is an industry consortium founded in 2009. Our mission is to ensure patient safety by enhancing the authenticity and quality of medicines around the world. To do this, Rx-360 embraces everyone: large and small pharma; innovators and generic manufacturers; CDMOs, suppliers, drug manufacturers and device manufacturers; producers of APIs, excipients and packaging materials — whether regulated or non-regulated; providers of logistic services and analytical services; dosage form manufacturers and producers of chemicals and intermediates — any organization that is involved in the healthcare supply chain is welcome.

Written By: Guy Villax

CEO, Hovione Guy Villax has been the Chief Executive Officer of Hovione since 1997. Prior to that, he held positions with Price Waterhouse in London and Hovione in the Far East. Guy has been a Member of the Board of CEFIC’s European Fine Chemicals Group since 2004, as well as a Member of the Board of Rx-360 since 2010 and is currently Vice-Chair. He has a degree in accounting and financial management from the University College at Buckingham.

Article Originally Published in Pharma’a Almanac – Nice Insights’s Content Community

Read More